Ofir Levi
Keine laufenden Positionen mehr
Profil
Ofir Levi has founded Bioassociate Consulting & Management Ltd in 2008.
He was the Chief Executive Officer of the company.
Dr. Levi's former jobs include being the Chief Executive Officer of Radmor Biocap LLC and Co-Head of Research at Adamas Capital Management (CY) Ltd.
He was also the Chairman of Vallon Pharmaceuticals, Inc. from 2018 to 2022.
Dr. Levi received a doctorate degree from Tel-Aviv University.
Ehemalige bekannte Positionen von Ofir Levi
| Unternehmen | Position | Ende |
|---|---|---|
| GRI BIOPAR | Vorsitzender | 28.03.2022 |
| Radmor Biocap LLC | Vorstandsvorsitzender | 01.01.2011 |
Adamas Capital Management (CY) Ltd.
 Adamas Capital Management (CY) Ltd. Investment ManagersFinance Adamas Capital Management (CY) Ltd. is an independent alternative asset manager headquartered in Limasol, Cyprus. The firm manages assets on behalf of institutional clients and high net worth investors. | Direktor der Forschung - Eigenkapital | - |
| Bioassociate Consulting & Management Ltd | Vorstandsvorsitzender | - |
Ausbildung von Ofir Levi
| Tel-Aviv University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
| Bioassociate Consulting & Management Ltd | Finance |
Adamas Capital Management (CY) Ltd.
Adamas Capital Management (CY) Ltd. Investment ManagersFinance Adamas Capital Management (CY) Ltd. is an independent alternative asset manager headquartered in Limasol, Cyprus. The firm manages assets on behalf of institutional clients and high net worth investors. | Finance |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
| Radmor Biocap LLC |
